Clinical Trial Update: Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update of the combination erlotinib and bevacizumab in patients with cancer of the esophagus or gastroesophageal junction; the study was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Tarceva (erlotinib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Esophageal Neoplasms, Esophageal Diseases | Phase 2 | Status: TERMINATED | Results posted: 2015-07-03